FIBRIA CELULOSE S Sample Clauses

FIBRIA CELULOSE S. A. By: /s/ Joao Xxxxxxxxx Xxxx Xx Name: Joao Xxxxxxxxx Xxxx Xx Title: CFO and Investor Relations Officer By: /s/ Xxxxxxxxx Xxxxxxxxx Xxxxxx Xxxxxxx Name: Xxxxxxxxx Xxxxxxxxx Xxxxxx Xxxxxxx Title: Industrial Operations & Engineering Director (Indenture) DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee, Registrar, Transfer Agent and Paying Agent By: Deutsche Bank National Trust Company By: /s/ Xxxxxxx R Ring Name: Xxxxxxx R Ring Title: Vice President By: /s/ XXXXX XXXXXXX Name: XXXXX XXXXXXX Title: VICE PRESIDENT STATE OF NEW JERSEY ) ) to wit COUNTY OF XXXXXX ) On this 3rd day of March, 2011, before me, a notary public, personally appeared Xxxxxxx X. Ring, Vice President and Xxxxx Xxxxxxx, Vice President, to me personally known who being duly sworn, did say that they are the Authorized Signatories of Deutsche Bank National Trust Company, two of the persons described in and which executed the foregoing instrument, and acknowledges said instrument to be the free act and deed of said persons. By: /s/ [ILLEGIBLE] Notary Public New Jersey Xxxxxxx Xxxxxxxxxx Commission Expiry: August 17, 2012 RULE 144A/REGULATION S APPENDIX PROVISIONS RELATING TO INITIAL SECURITIES
Sample 1
AutoNDA by SimpleDocs
FIBRIA CELULOSE S. A. By: Name: Title: By: Name: Title: [Form of Reverse of Security] This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be issued in one or more tranches of one or more series under an Indenture, dated as of [·], 2017 (herein called the “Indenture”, which term shall have the meaning assigned to it in such instrument), between the Company and Deutsche Bank Trust Company Americas, as trustee (herein called the “Trustee”, which term includes any successor trustee under the Indenture), and reference is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof [if applicable, insert — , limited in aggregate principal amount to U.S.$[ ]]. [If applicable, insert — The Securities of this series are subject to redemption upon not less than [ ] days’ nor more than [ ] days’ notice, at any time [if applicable, insert — on or after [ ], 20[ ]], as a whole or in part, at the election of the Company, at the following Redemption Prices (expressed as percentages of the principal amount): If redeemed [if applicable, insert — on or before [ ], [ ]%, and if redeemed] during the 12-month period beginning [ ] of the years indicated, Redemption Year Redemption Price Redemption Year Redemption Price and thereafter at a Redemption Price equal to [ ]% of the principal amount, together in the case of any such redemption with accrued interest to, but excluding, the Redemption Date, but interest installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the Holders of such Securities or one or more Predecessor Securities, of record at the close of business on the relevant Record Dates referred to on the face hereof, all as provided in the Indenture.] [If the Security is subject to redemption of any kind, insert — In the event of redemption of this Security in part only, a new Security or Securities of this series for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof.] [If the Security is not subject to redemption, insert—This Security is not redeemable prior to Stated Maturity.] The Indenture contains provisions for defeasance at any time of...
Sample 1
FIBRIA CELULOSE S. A. (nova denominação da Votorantim Celulose e Papel S.A.), com sede em São Paulo, Xxxxxx xx Xxx Xxxxx, xx Xxxxxxx Xxxxxx, 0000, 0x andar, Xxxxxxxxx Xxxxx, CEP 01419-001, inscrita no Cadastro Nacional de Pessoa Jurídica do Ministério da Fazenda (“CNPJ/MF”) sob o nº 60.643.228/0001-21, neste ato representada na forma de seu Estatuto Social (doravante designada simplesmente “CEDENTE”),de outro lado:
Sample 1
FIBRIA CELULOSE S. A., com sede em São Paulo, Xxxxxx xx Xxx Xxxxx, xx Xxxxxxx Xxxxxx, 0000, 0x andar, Xxxxxxxxx Xxxxx, CEP 01419-001, inscrita no CNPJ/MF sob o nº 60.643.228/0001-21, neste ato representada na forma de seu Estatuto Social (doravante designada “Vendedora”); E, DO OUTRO LADO:
Sample 1
FIBRIA CELULOSE S. A. Fibria Overseas Finance Ltd. Xxx Xxxxxxxx Xxxxx, 302— Torre B, 3º andar 04551-010 São Paulo, SP Brazil Facsimile: +00 (00) 0000-0000 Attention: General Counsel Any party hereto may change the address or facsimile number for receipt of communications by giving written notice to the others.
Sample 1
FIBRIA CELULOSE S. A., a publicly held company with head offices in the city of São Paulo, State of São Paulo, at Alameda Santos, 1357, 6th floor, enrolled with the General Taxpayers’ Registry (CNPJ/MF) under No. 60.643.228/0001-21 (“SELLER”, and jointly with PURCHASER, defined herein as “Parties”) and
Sample 1
FIBRIA CELULOSE S. A. Alameda Xxxxxx, 0000, 0xx xxxxx Xxx Xxxxx, XX 000000-000 Facsimile: (55-11) [ ] Attn.: Xx. Xxxxxxx Xxxxxxxxx Castelli e-mail: xxxxxxx.xxxxxxxx@xxxxxx.xxx.xx with copy to: Mr. Xxxxxxx de A. P. Andretto email: xxxxxxx.xxxxxxxx@xxxxxx.xxx.xx with copy, which shall not constitute a notice, to: Demarest e Xxxxxxx Advogados Xx. Xxxxxxx xx Moraes, 1.201, São Paulo, SP, Brazil Facsimile: +00 00 0000-0000 Attn.: Paulo Xxxxx Xxxxxx xx Xxxxx e-mail: xxxxxx@xxxxxxxx.xxx.xx or to such other address furnished in writing by such Party.
Sample 1
AutoNDA by SimpleDocs
FIBRIA CELULOSE S. A., a company with its principal place of business in the City of São Paulo, State of São Paulo, at Xxxxxxx Xxxxxx, Xx. 0000, 0xx xxxxx, Xxxxxxxx xx Xxxxxxxxx Xxxxx, Postal Code 01419-001, enrolled with the National Corporate Taxpayers Register of the Ministry of Finance under CNPJ/MF No. 60.643.228/0001-21, herein represented according to its Bylaws (hereinafter referred to as “Seller”); AND, ON THE OTHER PART:
Sample 1
FIBRIA CELULOSE S. A. Alameda Xxxxxx, 1357, 6º andar São Paulo - SP 01419-001 Attention: Xxxxxx Xxxxxxx Xxxx Xxxxxx — Diretor-Presidente (CEO) With copy to: Xxxxxxx Xxxxxxxx - Diretor Jurídico (General Counsel) With copy (that shall not be construed as notice) to: Paulo Xxxxx Xxxxxx xx Xxxxx Xxxxxxxx e Xxxxxxx Advogados Xx. Xxxxxxx xx Xxxxxx, 1201 São Paulo - SP 05419-001 If to Buyer:
Sample 1

Related to FIBRIA CELULOSE S

  • Nutzung Und Beschränkungen (a) Gemäß den Bestimmungen dieses Lizenzvertrags erteilt dir Apple hiermit eine eingeschränkte, einfache Lizenz zur Nutzung der Apple-Software auf einem einzigen Apple-Gerät. Ausgenommen wie in Absatz 2(b) unten gestattet und vorbehaltlich separater Lizenzvereinbarungen zwischen dir und Apple ist im Rahmen dieses Lizenzvertrags die Existenz der Apple-Software auf mehr als einem Apple-Gerät gleichzeitig nicht gestattet. Xxxxxx ist es untersagt, die Apple-Software zu verteilen oder über ein Netzwerk bereitzustellen, in dem sie von mehr als einem Gerät gleichzeitig verwendet werden kann. Diese Lizenz gewährt dir keinerlei Rechte zur Nutzung von Apple eigenen Benutzeroberflächen und anderem geistigem Eigentum an Design, Entwicklung, Fertigung, Lizenzierung oder Verteilung von Drittanbietergeräten und -zubehör oder Drittanbietersoftware für die Verwendung mit Geräten. Einige dieser Rechte stehen unter separaten Lizenzen von Apple zur Verfügung. Wenn du weitere Informationen zur Entwicklung von Drittanbietergeräten und -zubehör für Geräte wünschst, besuche bitte die Website xxxxx://xxxxxxxxx.xxxxx.xxx/programs/mfi/. Wenn du weitere Informationen zur Entwicklung von Software für Geräte wünschst, besuche bitte die Website xxxxx://xxxxxxxxx.xxxxx.xxx.

  • VOETSTOOTS The PROPERTY is sold:

  • Exportbepalingen Het is u niet toegestaan de Apple software te gebruiken of anderszins te exporteren of te herexporteren, behalve voor zover toegestaan krachtens de wetten van de Verenigde Staten en van het rechtsgebied waarin u de Apple software hebt verkregen. In het bijzonder, maar zonder beperking, is het u niet toegestaan de Apple software te exporteren of te herexporteren (a) naar een land waarvoor door de Verenigde Staten een embargo is ingesteld of (b) naar enige persoon die voorkomt op de door het U.S. Treasury Department samengestelde lijst van "Specially Designated Nationals" of op de door het U.S. Department of Commerce samengestelde "Denied Person’s List" of "Entity List". Door de Apple software te gebruiken, verklaart u dat u zich niet bevindt in een dergelijk land of op een van de bovengenoemde lijsten voorkomt. U verklaart tevens dat u de Apple software niet zult gebruiken voor doeleinden die verboden zijn volgens de wetten van de Verenigde Staten met inbegrip van, maar niet beperkt tot, de ontwikkeling, het ontwerp, de fabricage of productie van raketten, nucleaire, chemische of biologische wapens.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Gouvernement des États-Unis Le logiciel et la documentation constituent des « Commercial Items » (éléments commerciaux), tel que ce terme est défini dans la clause 48 C.F.R. (Code of Federal Rules) §2.101, consistant en « Commercial Computer Software » (logiciel) et « Commercial Computer Software Documentation » (documentation), tels que ces termes sont utilisés dans les clauses 48 C.F.R. §12.212 ou 48 C.F.R. §227.7202. Conformément à la clause 48 C.F.R. §12.212 ou 48 C.F.R. §227.7202-1 à 227.7202-4, le « Commercial Computer Software » et le « Commercial Computer Software Documentation » sont fournis sous licence au gouvernement des États-Unis (a) uniquement comme « Commercial Items » et (b) uniquement accompagnés des droits octroyés à tous les autres utilisateurs conformément aux termes et conditions ci-inclus. Droits non publiés réservés en vertu de la législation des droits d’auteur en vigueur aux États-Unis.

  • Vlastnictví Zdravotnické zařízení si ponechá a bude uchovávat Zdravotní záznamy. Zdravotnické zařízení a Zkoušející převedou na Zadavatele veškerá svá práva, nároky a tituly, včetně práv duševního vlastnictví k Důvěrným informacím (ve smyslu níže uvedeném) a k jakýmkoli jiným Studijním datům a údajům.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

Time is Money Join Law Insider Premium to draft better contracts faster.